Effect of Dash Diet and Acupuncture on Hypertention in Postmenopausal Women

Postmenopausal Disorder Clinical Trial

Official title:

Effect of Dash Diet and Acupuncture on Hypertention in Postmenopausal Women

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06015919
• Other study ID #: P.T.REC/012/003872
• Status: Completed
• Phase: N/A
• Start date: December 5, 2022
• Est. completion date: August 20, 2023

Study information

• Verified date: August 2023
• Source: Cairo University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

A study of effect of dash diet and acupuncture on hypertension in postmenopausal women

Description:

45 of post menopausal women divided into three groups A,B,C

• Group (A): It will include 15 post-menopausal women who will be treated by DASH diet and anti-hypertensive drugs.

• Group (B): It will include 15 post-menopausal women who will be treated by acupuncture and anti-hypertensive drugs.

• Group (C): It will include 15 post-menopausal women who will be treated by DASH diet, acupuncture and anti-hypertensive drugs.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 45
• Est. completion date: August 20, 2023
• Est. primary completion date: April 25, 2023
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 50 Years to 60 Years

Eligibility

Inclusion Criteria:

• Their body mass index will be ranged from 25 -29.9 kg/m2

• All patients will be medically stable when attending the study.

• The DASH eating plan of 1800 kcal per day will be used in the study.

Exclusion Criteria:

• Auditory and visual problems.

• Chronic renal failure.

• Myocardial infarction or arrythmias with heart failure.

Related Conditions & MeSH terms

• Postmenopausal Disorder

Intervention

Behavioral:
• dash diet
Group (A): It will include 15 post-menopausal women who will be treated by DASH diet and anti-hypertensive drugs. Group (B): It will include 15 post-menopausal women who will be treated by acupuncture and anti-hypertensive drugs. Group (C): It will include 15 post-menopausal women who will be treated by DASH diet, acupuncture and anti-hypertensive drugs.

Device:
• Acupuncture
acupuncture

Locations

Country	Name	City	State
Egypt	Alaa Nabil Elsayed Mohamed	Abu hammad	Elsharqia

Sponsors (2)

Lead Sponsor	Collaborator
Cairo University	faculty of physical therapy

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	assessment of quality of life	it will be measured by sf 36 questionnaire pre and post treatment	3 months
Primary	blood pressure	it will be measured by sphygmomanometer pre and post treatment	3 months
Secondary	sodium and potassium levels	it will be measured by blood analysis pre and post treatment	3 months